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Summary
Objective: To compare matrix composition and glycosaminoglycan (GAG) ﬁne structure among ﬁve scaffolds commonly used for in vitro
chondrocyte culture and cartilage tissue engineering.
Design: Bovine articular chondrocytes were seeded into agarose, alginate, collagen I, ﬁbrin and polyglycolic acid (PGA) constructs and
cultured for 20 or 40 days. In addition to construct DNA and sulfated GAG (sGAG) contents, the D-disaccharide compositions of the
chondroitin/dermatan sulfate GAGs were determined for each scaffold group via ﬂuorophore-assisted carbohydrate electrophoresis (FACE).
Results: Signiﬁcant differences were found in cell proliferation and extracellular matrix accumulation among the ﬁve scaffold groups.
Signiﬁcant cell proliferation was observed for all scaffold types but occurred later (20e40 days) in PGA constructs compared to the other
groups (0e20 days). By 40 days, agarose constructs had the highest sGAG to DNA ratio, while alginate and collagen I had the lowest levels.
Quantitative differences in the D-disaccharide composition of the GAGs accumulated in the different scaffolds were also found, with the most
striking variations in unsulfated and disulfated D-disaccharides. Agarose constructs had the highest fraction of disulfated residues and the
lowest fraction of unsulfated residues, with a 6-sulfated/4-sulfated disaccharide ratio most similar to that of native articular cartilage.
Conclusions: Thesimilaritiesanddifferencesamongscaffolds inproteoglycanaccumulationandGAGcompositionsuggest that thescaffoldmaterial
directly or indirectly inﬂuences chondrocyte proteoglycan metabolism and may have an inﬂuence on the quality of tissue engineered cartilage.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
The functionof healthy cartilage resides in its ability to provide
resistance to compressive, shear and tensile forces that
occur during normal joint motion. This ability arises from the
unique architecture of the matrix components found in
articular cartilage. The ﬁbrillar collagen network is organized
and stabilized through molecular cross-links that restrain the
swelling pressure exerted by a high concentration of
negatively charged proteoglycans. Proteoglycans are known
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Received 15 September 2004; revision accepted 22 April 2005.82to indirectly inﬂuence chondrocyte activity, either through
cellematrix interactions or by binding speciﬁc growth factors
in the extracellular matrix, thereby modifying their temporal
and spatial effects1. Many of these biological interactions
involve the highly negative glycosaminoglycan (GAG)
chains, which are covalently attached to the protein cores
of individual proteoglycan molecules1. In articular cartilage,
the GAGs are mainly chondroitin sulfate (CS) and keratan
sulfate chains found on the large, aggregating proteoglycan
aggrecan, as well as a small proportion of dermatan sulfate
(DS) chains1. Aggrecan monomers consist of a protein core
to which are attached CS chains containing predominately
4-sulfated disaccharides (DDi-4S) or 6-sulfated disaccha-
rides (DDi-6S)2,3. These negatively charged GAGs produce
a swelling pressure through interactions with the ionic
interstitial ﬂuid1, contributing to the compressive stiffness of
the tissueandmaintaining tensile stress in the type II collagen
network. While the collagen network is somewhat metabol-
ically static4, aggrecan undergoes a distinct turnover pro-
cess5,6 in which catabolic cleavage7,8 and removal of
molecules from the extracellular matrix are in balance with
synthesis and deposition of newmolecules9,10. Maintenance
of the appropriate structure and concentration of the8
829Osteoarthritis and Cartilage Vol. 13, No. 9proteoglycans is critical for maintaining healthy cartilage
capable of resisting compressive loads.
Alterations in GAG sulfation have been associated with
aging and degeneration of articular cartilage. Changes
include a decreased keratan sulfate to CS ratio and
a decrease in overall GAG chain length1,11. The internal
disaccharide (D-disaccharide) composition of CS chains
shifts with age, with an increased ratio of DDi-6S/DDi-4S
and a decrease in unsulfated disaccharides (DDi-0S)1,11.
The non-reducing termini of CS chains from aggrecan
puriﬁed from fetal to elderly human cartilage contain
distinctly different ratios of variably sulfated N-Acetylgalac-
tosamine (Gal NAc) residues which are characteristic of the
age of the patient12, with an age-related increase in 4,6-
disulfated residues and a corresponding decrease in 4-
sulfated residues. Additionally, a decrease in CS terminal
4,6-disulfated residues and an increase in CS terminal 4-
sulfated residues have been described for OA cartilage,
perhaps due to a lower propensity to the speciﬁc 6-
sulfotransferase involved in the terminal 4,6 reaction2,13e17.
While distinct functional implications of CS sulfation
patterns in cartilage have not yet been elucidated, recent
work has suggested fundamental biological functions for
chondroitin, CS and DS in other systems. These GAGs
have been implicated in growth factor and chemokine
signaling, play critical roles in the development of the
central nervous system, and function as receptors for
various pathogens18e21. Unsulfated chondroitin has been
found to be integral in the morphogenesis and cell division
of C. elegans22. These functions are directly related to the
sulfation patterns of the GAG chains.
Understanding the degree and level of inﬂuence the CS
ﬁne structure plays in the biological activity of chondrocytes
may provide a more in depth perspective on not only the
state of native cartilage (i.e., osteoarthritic, injured, healthy)
but also the development of engineered cartilages. A key
component of most tissue engineering approaches to
regenerating articular cartilage is the choice of a scaffold
material. The three-dimensional scaffold provides support
for chondrocytes to proliferate and maintain their differen-
tiated function23e26. In the case of undifferentiated cell
populations (e.g., bone marrow stromal cells, mesenchymal
stem cells), the choice of scaffold may inﬂuence the
differentiation and phenotypic stability of the cell popula-
tions. Scaffolds commonly used for the tissue engineering
of cartilage include degradable synthetic polymers (e.g.,
polyglycolic acid (PGA)27,28, polylactic acid29), ﬁbrillar
protein gels (e.g., collagen30, ﬁbrin31,32), and polysaccha-
ride gels (e.g., agarose33,34, alginate35,36). Matrix formation
in these systems is typically quantiﬁed by measures of
gross biochemical composition such as the total sulfated
GAG (sGAG) content. While these gross measures are
useful, more deﬁnitive molecular information is required to
fully understand the biochemical characteristics of tissue
engineered cartilage matrices. Therefore, this study exam-
ined the nature of the proteoglycan/GAG matrices synthe-
sized by chondrocytes seeded in different scaffold
materials. In addition to differences in total GAG content,
ﬂuorophore-assisted carbohydrate electrophoresis (FACE)
revealed differences in CS/DS GAG ﬁne structure among
different scaffold materials.
Methods
MATERIALS
Bovine stiﬂe joints were from Research 87 (Marlborough,
MA). Collagenase type 2 was fromWorthington Biochemical(Lakewood, NJ). Fetal bovine serum (FBS), high glucose
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM), phosphate
buffered saline (PBS), non-essential amino acids (NEAA),
sodium pyruvate, L-glutamine and gentamicin sulfate were
from Gibco BRL (Rockville, MD). Low gelling temperature
agarose (type VII), ascorbate, 1,9-dimethyl-methylene blue
(DMMB), calf thymus DNA, Hoechst 33258 dye and
Safranin-O were from Sigma (St. Louis, MO). Rat-tail
collagen type I was from Collaborative Biomedical Products
(Bedford, MA). 6-Aminocaproic acid was from Acros
Organics (Fairlawn, NJ). PGA felts were from Albany
International (Mansﬁeld, MA). Sodium alginate (UP LVG)
was from Pronova Biomedical (Oslo, Norway). Bovine
ﬁbrinogen and bovine thrombin were from ICN Biomedicals
(Irvine, CA). 2-Aminoacridone hydrochloride was from
Molecular Probes (Eugene, OR). Mono composition gels
and mono gel running buffer were from Glyko (Novato, CA).
Disaccharide standards, chondroitinase ABC, chondroiti-
nase AC and hyaluronidase were from Calbiochem (La
Jolla, CA). Imaging was done with an EDAS 120 imaging
system from Eastman Kodak (New Haven, CT).
CONSTRUCT ASSEMBLY AND CELL CULTURE
Bovine articular chondrocytes were isolated from the stiﬂe
joints of two immature (!5 weeks) donor animals. Tissue
was excised from the patellofemoral grooves, minced and
digested in DMEMwith 0.2% collagenase for 24 h in a 37(C,
5%CO2 incubator. After centrifugation at 160! g, cells were
washed twice with Ca2C, Mg2C-free PBS and counted with
a Coulter counter. Donor cells were kept separate and
parallel duplicate experiments were run. Non-digested
samples of cartilage were maintained as controls during the
course of the experiment. Cells were seeded at a ﬁnal density
of 15! 106 cells/ml in 1.5% agarose, 0.75% sodium
alginate, 2 mg/ml type I collagen (rat tail), and 50 mg/ml
ﬁbrin. Cells were also seeded on PGA felt at a target density
of 15! 106 cells/ml, but a low seeding efﬁciency resulted in
an actual initial cell density of approximately 4! 106 cell/ml.
It should be noted that seeding density may affect chon-
drocyte matrix synthesis and viability, perhaps due to
diffusional limitations at high cell densities34,37. All constructs
except PGA were cast in 12 mm diameter by 3 mm deep
cylindrical wells in custom machined polycarbonate molds
that were autoclave sterilized prior to gel casting. Agarose
constructs were assembled by autoclaving 3% LMP agarose
in 1!Ca2C, Mg2C-free PBS and then cooling the solution to
42(C.Anequal volumeof cells suspendedat 30! 106 cells/ml
in 2! DMEM and 20% FBS was added, and the solution
was cooled in the molds. Alginate constructs were similarly
assembled by autoclaving 1.5% alginic acid in 1! Ca2C,
Mg2C-free PBS to solubilize and sterilize, cooling to 37(C,
adding 30! 106 cells/ml in Ca2C, Mg2C-free PBS and
polymerizing the gels in the molds with 102 mM CaCl2.
Collagen constructs were assembled by suspending
15! 106 cell/ml in a solution containing 10% FBS, 0.5!
DMEM and 2 mg/ml acid solubilized rat-tail collagen type I
and titrating the solution to neutral pH with 0.1 M NaOH.
Constructs were allowed to polymerize in a 37(C, 5% CO2
incubator for 30 min before transfer to 24-well plates with
2 ml of media. Fibrin constructs were assembled by
suspending cells in a solution of bovine ﬁbrinogen, FBS,
6-aminocaproic acid, and DMEM. Bovine thrombin was
dissolved in 40 mM CaCl2, and 100 ml of the thrombin
solution was placed into each well of a polycarbonate mold,
followed by 200 ml of the cell/ﬁbrinogen mixture. Final
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50 U/ml thrombin, 10% FBS, 2 mg/ml 6-aminocaproic acid,
and 15! 106 cells/ml. Constructs were allowed to polymerize
in a 37(C, 5% CO2 incubator for 30 min. PGA felts (45 mg/
cm3 polymer density; 12e15 mm ﬁber thickness; 10 mm
diameter by 2 mm thickness) were prewetted overnight in
high glucose DMEM containing 10% FBS. PGA felts were
then seeded by repeatedly pipetting 1 ml of cell suspension
(1.2! 106 cells/ml) onto each felt and cultured on a shaker
plate at 300 rpm for 24 h. Additionally, native cartilage
samples from the same joints were maintained in identical
culture conditions for the comparison of D-disaccharide
composition.
Constructs and native cartilage samples (nZ 6 per group
per endpoint) were cultured in 24-well plates with 2 ml of
DMEM containing 10% FBS, 0.1 mM NEAA, 4 mM
L-glutamine, 5 mg/ml gentamicin sulfate and 50 mg/ml
ascorbic acid. For the PGA felts, the culture dish wells
had been pre-coated with a thin layer of 1% agarose. As in
previous studies on dorsal root ganglia38, smooth muscle
cells39 and chondrocytes40,41, 6-aminocaproic acid (2 mg/
ml) was added to the media of ﬁbrin constructs to inhibit
proteolytic degradation. Media were changed every 2 days,
with samples retained for analysis of the sGAG released
from the constructs. After 20 and 40 days, constructs were
weighed, lyophilized, reweighed, and digested in 1 ml of
100 mM ammonium acetate buffer with 250 mg/ml Pro-
teinase K at 60(C for 24 h. Portions of each digest were
assayed for total DNA using the Hoechst 33258 assay with
calf thymus DNA as a standard42 and sGAG using the
DMMB assay43,44 with shark cartilage CS as a standard.
HISTOLOGICAL SAMPLE PROCESSING
AND CHARACTERIZATION
Additional samples were rinsed in PBS, transferred to
10% neutral-buffered formalin for 48 h, and then stored in
70% ethanol (nZ 2 per group per endpoint) to reduce the
solubility of the GAG side chains. Samples were sub-
sequently embedded in parafﬁn and sectioned at 5 mm.
Sections were stained with Safranin-O to visualize sGAG
distribution45.
D-DISACCHARIDE ANALYSIS
The CS and DS (CS/DS) D-disaccharide compositions of
deposited GAGs were quantiﬁed for all 20- and 40-day
constructs using FACE46e50. GAGs were ethanol precipitat-
ed (ﬁnal concentration of 75% v/v) from the Proteinase K
digests and aliquots from each construct containing 5 mg of
sGAG (as determined by the DMMB dye assay) were further
enzymatically processed with 15 mU of chondroitinase ABC
and 100 mU hyaluronidase in 100 mL of 50 mM ammonium
acetate buffer at 37(C for 16 h. Buffer was evaporated and
digestion products were ﬂuorescently labeled for 16 h at
37(Cwith 15 mL of 0.1 M2-aminoacridone and 1.0 M sodium
cyanoborohydride. After ﬂuorescent labeling, 15 mL of
glycerol was added to each sample. Portions (5 mL) of these
samples were electrophoretically separated using mono-
saccharide FACEgels. Fluorescent bandswere visualized at
300 nm illumination using a Kodak EDAS 120 gel imaging
system. Band intensities were ﬁt with a Gaussian model and
converted to pmol amounts using a standard ladder
containing a range of concentrations of puriﬁed D-disacchar-
ides (25e250 pmol) for product identiﬁcation and quantiﬁca-
tion (50 pmol of disulfated disaccharides (DDi-4,6S), 75 pmol
hyaluronic acid, 100 pmol of DDi-6S, 150 pmol of DDi-4S,and 200 pmol of DDi-0S). Relative D-disaccharide composi-
tionwas expressed as a percent of total detected internal CS/
DS D-disaccharides for DDi-0S, DDi-4S, DDi-6S and DDi-
4,6S and as the ratio of DDi-6S/DDi-4S. For comparison,
native articular cartilage samples that had been cultured for
comparable periods were also analyzed via FACE.
STATISTICAL ANALYSIS
As no substantial differences in proliferation or matrix
production were found between the donors, data were
analyzed with two factor (scaffold, time point) general linear
models with Tukey’s test for pair-wise comparisons. Differ-
ences were considered signiﬁcant at P! 0.05. All results
are reported for pooled data from the two donors.
Results
HISTOLOGY
For a given construct type, no differences were noted in
the organization of cells or sGAG matrix between histolog-
ical samples from the 20- and 40-day time points. Cells in all
scaffolds displayed predominantly a rounded morphology
[Fig. 1(BeF)] similar to chondrocytes in their native matrix
[Fig. 1(A)]. Agarose constructs [Fig. 1(B)] included isolated
cells and multiple cell clusters surrounded by a pericellular
matrix dense in sGAG, while the other constructs contained
primarily isolated cells or small cell clusters. The intensity of
pericellular matrix staining in the four other scaffold
materials was either considerably less intense (alginate,
collagen and PGA) or less extensive (ﬁbrin) than that in
agarose. Alginate constructs [Fig. 1(C)] also displayed
intense pericellular matrix staining, with a relatively high
background level of staining due to the negatively charged
alginate. Collagen constructs [Fig. 1(D)] contained uniformly
distributed cells and diffuse matrix staining. In contrast,
ﬁbrin constructs [Fig. 1(E)] displayed a very immediate
staining of sGAG surrounding either single cells or pairs of
cells. PGA constructs [Fig. 1(F)] contained islands with
relatively intense matrix staining and numerous cells
surrounded by regions apparently devoid of cells. Articular
cartilage, alginate and ﬁbrin constructs were surrounded by
a layer with little sGAG staining and cells with a more
ﬂattened morphology (images not shown).
DNA CONTENT
The relative changes in DNA content from initial seeding
to days 20 and 40 indicated differential increases in the
cellular contents among scaffold types (Fig. 2). The
increases in DNA contents of agarose and collagen
constructs were not signiﬁcantly different at either time
point (PO 0.8) and reached approximately 3.5 times the
initial seeding density. Agarose constructs had signiﬁcantly
greater increases in DNA content than alginate, ﬁbrin or
PGA constructs at both day 20 (P% 0.0002) and day 40
(P% 0.028). Collagen constructs had signiﬁcantly greater
increases in DNA content than ﬁbrin and PGA constructs at
day 20 (P% 0.0016) and day 40 (P% 0.0001), and
signiﬁcantly greater increases than alginate constructs at
day 40 (P! 0.0001) but not day 20 (PZ 0.061). There
were no signiﬁcant changes in DNA content between 20
and 40 days for any constructs except for PGA
(P! 0.0001). PGA constructs exhibited a small (25%)
increase in DNA content by day 20, followed by a substantial
831Osteoarthritis and Cartilage Vol. 13, No. 9Fig. 1. Representative interior sections stained with Safranin-O from (A) articular cartilage and (BeF) constructs cultured for 20 days.(109%, P! 0.0001) increase in DNA content between days
20 and 40, resulting in a net increase comparable to that
seen in the other construct types. At day 40, alginate, ﬁbrin
and PGA constructs had reached approximately 2.5 times
the original seeding density, with no statistically signiﬁcant
differences among these scaffolds.
sGAG PRODUCTION
The sGAG/DNA results indicated that constructs from all
scaffold groups accumulated extracellular matrix over the
40-day culture period (Fig. 3). Between days 20 and 40,
agarose constructs exhibited a continued increase in
sGAG/DNA (P! 0.0001) while alginate, collagen, and
ﬁbrin constructs exhibited no signiﬁcant change in sGAG/
DNA. PGA constructs had signiﬁcantly lower sGAG/DNA at
day 40 as compared to day 20 (P! 0.0001), which can beattributed to the dramatic increase in DNA content over that
period. The patterns of matrix accumulation and cell content
changes resulted in differences in sGAG/DNA among
scaffolds at each time point. At day 20, PGA constructs
had signiﬁcantly higher sGAG/DNA than all other groups
(P! 0.0001), while alginate constructs had signiﬁcantly
lower sGAG/DNA than all groups (P% 0.0023) except
collagen constructs (PZ 0.45). At day 40, agarose con-
structs had signiﬁcantly higher sGAG/DNA than all other
groups (P! 0.0001), while collagen and alginate con-
structs had signiﬁcantly lower sGAG/DNA (P% 0.0003 and
P! 0.0001, respectively) than all other groups.
The sGAG detected in the media indicated that sGAG
was released from all constructs through the 40-day culture
period (Fig. 4) Overall, the average sGAG release rate was
lowest for alginate constructs and comparable for agarose,
collagen and PGA constructs. The kinetics of sGAG release
were similar for agarose, alginate, collagen and ﬁbrin, withAgarose Alginate Collagen I Fibrin PGA
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Fig. 2. Construct DNA contents. (A) DNA contents at day 0. PGA constructs had substantially fewer cells due to a low seeding density. (B)
DNA contents relative to day 0 levels for each scaffold type after 20 and 40 days of culture. Asterisks indicate P! 0.05 vs all other scaffolds at
the same time point, daggers indicate P! 0.05 vs some other scaffolds at the same time point, and stars at day 20 indicate P! 0.05 vs the
day 40 value for the same scaffold. Individual differences are discussed in the text (meanG S.E.M., NZ 12).
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a signiﬁcant (except for agarose) drop in sGAG release
on days 31e40. In contrast, the sGAG release rate for PGA
constructs was highest on days 1e10 and decreased
steadily though day 40.
D-DISACCHARIDE COMPOSITION
As in native articular cartilage, DDi-4S and DDi-6S
comprised the majority (~80%) of CS/DS-derived
D-disaccharides (Table I), although the fraction of each
D-disaccharide varied somewhat. Overall, the fraction of
DDi-4S was lower at day 20 than at day 40 (PZ 0.0025),
although the pair-wise comparisons did not indicate
a signiﬁcant increase for any individual scaffold. The
fraction of DDi-4S was higher for agarose than for all other
scaffolds (P% 0.0002). This pair-wise difference was
signiﬁcant at day 20 versus all scaffolds (P! 0.0001)
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Fig. 3. Construct sGAG content normalized to DNA content after 20
and 40 days of culture. Asterisks indicate P! 0.05 vs all other
scaffolds at the same time point, daggers indicate P! 0.05 vs
some other scaffolds at the same time point, and stars at day 20
indicate P! 0.05 vs the day 40 value for the same scaffold.
Individual differences are discussed in the text (meanG S.E.M.,
NZ 12).
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Fig. 4. Average sGAG release rates during four 10-day intervals
(meanG S.E.M., NZ 20).except collagen (PZ 0.053) and was signiﬁcant at day 40
vs ﬁbrin (PZ 0.031) and PGA (PZ 0.034) but not collagen
(PZ 0.055) or alginate (PZ 0.25). Other than a higher
fraction for collagen compared to PGA at day 20
(PZ 0.014), there were no other signiﬁcant differences in
DDi-4S among scaffolds at either time point. The fraction of
DDi-6S was not signiﬁcantly different between day 20 and
day 40 (PO 0.19), but did vary among scaffolds
(P! 0.0001). Among the construct groups, the fraction of
DDi-6S was smaller for agarose than for all other scaffolds
(P% 0.032) and was smaller for collagen than for alginate
(PZ 0.0017) and PGA (PZ 0.021). The ratio of DDi-6S/
DDi-4S in the constructs was generally somewhat higher
than that in native tissue explants (Fig. 5). The ratio of DDi-6S/
DDi-4S was slightly higher at day 20 than at day 40
(PZ 0.009), was lower for agarose than for all other
scaffolds (P% 0.0019), and was lower for collagen than
for alginate (PZ 0.007) and PGA (PZ 0.0075).
Overall, the fraction of DDi-4,6S was signiﬁcantly higher
at day 20 than at day 40 (PZ 0.0017), but other than
a slightly higher level for ﬁbrin constructs at day 40
(PZ 0.078) there were no signiﬁcant differences in the
fraction of DDi-0S between days 20 and 40. There were
signiﬁcant differences among scaffold types in the fractions
of both DDi-0S and DDi-4,6S. Alginate constructs had
a lower fraction of DDi-0S than all other scaffold groups
(P! 0.0001) and a higher fraction of DDi-4,6S than all
other scaffold groups (P! 0.0001). In contrast, collagen
constructs had a higher fraction of DDi-0S than all other
scaffold groups (P% 0.023) and a lower fraction of DDi-4,6S
than alginate, ﬁbrin or PGA (P% 0.0001) constructs. Other
than a signiﬁcantly higher level of DDi-0S for agarose than
for ﬁbrin at day 20 (PZ 0.0084), there were no other signiﬁ-
cant differences among scaffold groups in the fractions of
DDi-0S or DDi-4,6S.
Discussion
While a wide variety of biomaterials have been proposed
for use in cartilage tissue engineering, few studies have
quantitatively compared details of chondrocyte activity and
extracellular matrix production in different scaffold materials.
This study found signiﬁcant differences in cell proliferation
and extracellular matrix accumulation among ﬁve scaffolds
commonly used for chondrocyte in vitro culture studies and
cartilage tissue engineering. Over the ﬁrst 20 days, PGA
constructs had the lowest increase in cell content but the
greatest accumulation of sGAG per cell and the greatest
rate of sGAG release to the media. Between day 20 and
day 40, the sGAG/DNA of the other constructs was fairly
stable while that of PGA constructs decreased substantially
due to the substantial increase in cell proliferation in PGA
scaffolds. Chondrocytes in agarose synthesized the most
sGAG throughout the study, resulting in a substantially
higher sGAG/DNA than all other scaffolds at day 40.
Distinct differences between scaffolds were also noted in
the distributions of cells and matrix. The differences in the
distribution of the chondrocytes in the various scaffolds may
be due to inherent differences in the preparation required
for the various scaffolds or in how the cells interact with
particular scaffolds after seeding. Other possible reasons
for the cell clustering include the migration of cells into
colonies or localized cell death.
Furthermore, this study revealed substantial quantitative
differences in the D-disaccharide composition of the
proteoglycans accumulated in the different scaffolds.
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alginate constructs least resembled that of native articular
cartilage, whereas the proﬁle of agarose constructs most
closely resembled that of articular cartilage. The primary
notable difference in the levels of the monosulfated DDi-4S
and DDi-6S was for agarose constructs, which had a higher
fraction of DDi-4S, lower fraction of DDi-6S, and lower
DDi-6S/DDi-4S than all other scaffold groups. More strik-
ing differences were seen in the levels of DDi-0S and
DDi-4,6S. Alginate constructs had a lower fraction of
unsulfated residues and a higher fraction of disulfated
residues than other groups. Conversely, collagen con-
structs had the highest fraction of unsulfated residues and
the lowest fraction of disulfated residues. These patterns
suggest that some aspects of the construct environment
inﬂuence a tradeoff between incorporation of DDi-0S and
DDi-4,6S into newly synthesized proteoglycans. Further
studies would be necessary to identify the causes of the
observed differences in sulfation patterns (e.g., altered
sulfotransferase activity, altered ratios of proteoglycan
species, etc.). Interestingly, the inﬂuence of mechanical
stimulation on GAG disaccharide composition also appears
to depend on the cellular environment. Cyclic compression
of cartilage tissue explants had no effect on the internal
disaccharide composition of newly synthesized GAGs51,
while cyclic compression of chondrocytes in ﬁbrin con-
structs signiﬁcantly decreased the proportion of DDi-0S40.
Further exploration of variations between scaffolds in
response to mechanical stimulation will be important in
the development of mechanically functional engineered
cartilage constructs.
The similarities and differences among scaffolds in
proteoglycan accumulation and GAG composition were
consistent for both donor animals at both time points,
suggesting that the scaffold material directly or indirectly
inﬂuences chondrocyte proteoglycan metabolism. Prior to
the deposition of any extracellular matrix, chondrocyte
interactions with the scaffold would vary substantially
depending on the type of scaffold. Direct chondrocyte
binding to protein scaffolds such as collagen or ﬁbrin via
integrins or other cell surface receptors may inﬂuence
a variety of cellular functions52e54. In contrast, chondro-
cytes would initially be isolated from interactions with the
scaffold material when suspended in the agarose and
alginate hydrogels. In PGA scaffolds, chondrocytes initiallyadhere to and spread on serum proteins absorbed onto the
polymer mesh, resulting in an initial state somewhat similar
to monolayer culture55,56.
In each of these systems, chondrocytes would eventually
interact primarily with the new extracellular matrix produced
by the cells, but the accumulation of that matrix could be
inﬂuenced by the physical properties of the scaffold57. For
example, the highly permeable, macroscopically porous
PGA scaffolds initially provide little resistance to diffusion of
secreted proteins and proteoglycans, allowing much of the
newly synthesized material to escape the construct56,57.
Conversely, scaffolds such as alginate and agarose provide
substantial resistance to diffusion of large molecules,
resulting in more concentrated pericellular accumulation of
secreted matrix components57. Additionally, the biophysical
environment of the cell may vary between scaffolds. For
example, the agarose gel provides an electrochemically
neutral environment, while the negatively charged alginate
may affect both the ionic environment and the interstitial pH,
potentially inﬂuencing cell behavior and the ability of the
local environment to sequester important growth factors,
cytokines and chemokines.
While the functional implications of altered D-disaccharide
sulfation patterns in native or engineered cartilage are un-
known, there is evidence of structureefunction relationships
in other tissues and with other sGAGs. Oversulfation of CS/
DS chains containing GlcAb1-3GalNAc(4,6-O-disulfate) or
IdoAa1-3GalNAc(4,6-O-disulfate) in the large aggregating
proteoglycan versican affects its ability to bind to L- and P-
selectin and chemokines21. Additionally, any amount of
sulfation has been shown to inhibit the ability of versican to
interact with CD4421. It has been shown that oversulfated
CS chains play a role in the development of the brain.
Speciﬁcally, CS chains with oversulfated structures are
involved in neuronal adhesion, migration and neurito-
genesis58. Thus, the possibility exists that variations in the
sulfation of the CS chains in cartilage may alter the binding
of nutrients, chemokines and growth factors, thereby
inﬂuencing chondrocyte migration, differentiation, and
matrix production.
With advances in tissue engineering, it has become
apparent that more sophisticated methods of evaluating
engineered cartilage constructs need to be employed. In
this study, articular chondrocytes seeded into different
scaffolds exhibited differences in proliferation, the quantityTable I
GAG D-disaccharide contents derived from CS and DS after 20 and 40 days of culture. Levels for articular cartilage cultured for comparable
periods are included for visual comparison. Values are expressed as percentages of total D-disaccharide measured. Asterisks indicate
P! 0.05 versus all other scaffolds at the same time point and daggers indicate P! 0.05 versus some other scaffolds at the same time point
(meanG S.E.M., NZ 12)
DDi-0S DDi-6S DDi-4S DDi-4,6S
20 Days
Agarose 14.27G 0.31y 38.65G 0.46* 40.62G 0.61y 6.46G 0.12y
Alginate 7.43G 0.19* 44.49G 0.83y 34.99G 0.89y 13.08G 0.29*
Collagen I 16.89G 0.30* 40.82G 0.32y 37.51G 0.33y 4.78G 0.17y
Fibrin 11.86G 0.52y 42.93G 1.18y 35.46G 0.93y 9.75G 1.51y
PGA 13.51G 0.42y 42.59G 0.46y 33.99G 0.29y 9.91G 0.41y
Articular cartilage 12.56G 0.87 37.12G 0.51 45.10G 1.32 5.21G 0.26
40 Days
Agarose 14.91G 0.35y 38.20G 0.65* 40.26G 0.39y 6.63G 0.43y
Alginate 8.09G 0.31* 42.50G 1.60y 37.78G 1.70 11.63G 0.54*
Collagen I 17.69G 0.39* 40.41G 0.38y 37.17G 0.58 4.73G 0.23y
Fibrin 14.27G 0.70y 42.02G 0.94y 36.97G 0.97y 6.73G 1.65y
PGA 12.90G 0.50y 43.25G 0.48y 37.02G 0.49y 6.82G 0.26y
Articular cartilage 14.69G 0.76 36.53G 0.66 42.91G 0.99 5.87G 0.24
834 J. K. Mouw et al.: Variations in matrix among scaffoldsof matrix accumulated and the ﬁne structure of the newly
synthesized GAGs. It should be noted that many evolving
approaches to cartilage tissue engineering rely on either
passage expanded chondrocytes or chemically manipulated
progenitor cells, either of which would be expected to
continue differentiating towards a chondrocytic phenotype
within the construct environment. In such cases where
relatively rapid changes in phenotype are expected, the
inﬂuence of the scaffold environment on cell behavior and
matrix composition may be more pronounced. An appreci-
ation of the details of the extracellular matrix structure in
engineered tissues may be important in understanding the
relative maturity and health of the engineered tissue and the
degree to which engineered implants may differ from and
integrate with the surrounding native tissues.
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